Pelthos Therapeutics Inc. (PTHS)
NYSEAMERICAN: PTHS · Real-Time Price · USD
20.26
+0.11 (0.55%)
Oct 19, 2026, 4:00 PM EDT - Market closed
Pelthos Therapeutics Market Cap
Pelthos Therapeutics has a market cap or net worth of $77.56 million as of October 19, 2026. It is the 27,055th most valuable company in the world and the 4,305th biggest in the United States. Its market cap has decreased by 12.82% in one year.
Market Cap
77.56M
Enterprise Value
126.48M
1-Year Change
-12.82%
Global Rank
Country Rank
#4,305 United States
Category
ChartMarket Cap Chart
Since February 16, 2024, Pelthos Therapeutics's market cap has increased from $27.68M to $77.56M, an increase of 180.18%. That is a compound annual growth rate of 47.00%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 19, 2026 | 77.56M | -18.94% |
| Dec 31, 2025 | 95.69M | 2,376.40% |
| Dec 31, 2024 | 3.86M | -86.04% |
| Feb 16, 2024 | 27.68M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Cellectis | 84.89M |
| Aardvark Therapeutics | 83.16M |
| PDS Biotechnology | 81.90M |
| Tenax Therapeutics | 77.90M |
| Telomir Pharmaceuticals | 77.30M |
| Nutriband | 75.61M |
| Equillium | 75.46M |
| OKYO Pharma | 74.00M |